Healthcare Finance News August 5, 2024
JelloX Biotech has developed 3D pathology imaging technology with AI for spatial analysis to support precision cancer diagnoses.
Minnesota-based Mayo Clinic is joining forces with 3D imaging startup JelloX Biotech on artificial intelligence-powered imaging analysis technology.
JelloX previously participated in the fifth cohort of the Mayo Clinic and Arizona State University Alliance for Health Care MedTech Accelerator, a flagship program providing early-stage medical device and healthcare technology companies with curriculum to accelerate their go-to-market plans.
The company has developed 3D pathology imaging technology with AI for spatial analysis to support precision cancer diagnoses, with Mayo Clinic expected to further develop and validate the technology.
WHAT’S THE IMPACT
According to Mayo, cancer diagnoses using traditional 2D imaging methods can miss spatial...
Today's Sponsors
Today's Sponsor